VRTX Vertex Pharmaceuticals Inc / Ma

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$113.40B

Revenue (FY)

$12.00B 2025-12-31

Net Income (FY)

$3.95B

P/E (float-based)

28.7

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 875320 · SEC filings · revenue ranking · home